CCL28 production in HaCaT cells was mediated by different signal pathways from CCL27

Experimental Dermatology

Volumn 15, Issue 2, 2006, Pages 95-100

  Kagami, Shinji ^a   Saeki, Hidehisa ^a   Komine, Mayumi ^a   Kakinuma, Takashi ^a   Nakamura, Koichiro ^b   Tsunemi, Yuichiro ^a   Sasaki, Kiyo ^a   Asahina, Akihiko ^a   Tamaki, Kunihiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Epidermal growth factor receptor; Extracellular signal regulated kinases; Keratinocytes; Nuclear factor kappa B; p38mitogen activated protein kinases

Indexed keywords

CCL27 CHEMOKINE; CCL28 CHEMOKINE; CHEMOKINE; EPIDERMAL GROWTH FACTOR RECEPTOR; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4-(4-FLUOROPHENYL)-2-(4-HYDROXYPHENYL)-5-(4-PYRIDYL)IMIDAZOLE; BETA CHEMOKINE; CCL27 PROTEIN, HUMAN; CCL28 PROTEIN, HUMAN; CCR10 PROTEIN, HUMAN; CHEMOKINE RECEPTOR; IMIDAZOLE DERIVATIVE; INTERLEUKIN 1; LIGAND; PARTHENOLIDE; PYRIDINE DERIVATIVE; SESQUITERPENE;

ARTICLE; CELL STIMULATION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; KERATINOCYTE; PATHOGENESIS; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SKIN INFLAMMATION; BIOSYNTHESIS; CELL LINE; DERMATITIS; DRUG ANTAGONISM; DRUG EFFECT; IMMUNOLOGY; METABOLISM;

CELL LINE; CHEMOKINES; CHEMOKINES, CC; DERMATITIS; HUMANS; IMIDAZOLES; INTERLEUKIN-1; KERATINOCYTES; LIGANDS; MAP KINASE SIGNALING SYSTEM; NF-KAPPA B; PYRIDINES; RECEPTORS, CHEMOKINE; SESQUITERPENES; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33645128629     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2005.00390.x     Document Type: Article

References (23)

1. Zlotink A, Yoshie O. Chemokines: A new classification system and their role in immunity. Immunity 2000: 12: 121-127.
2. Morales J, Homey B, Vicari A P et al. CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells. Proc Natl Acad Sci USA 1999: 96: 14470-14475.
3. Kakinuma T, Saeki H, Tsunemi Y et al. Increased serum cutaneous T cell-attracting chemokine (CCL27) levels in patients with atopic dermatitis and psoriasis vulgaris. J Allergy Clin Immunol 2003: 111: 592-597.
4. Pan J, Kunkel E J, Gosslar U et al. A novel chemokine ligand for CCR10 and CCR3 expressed by epithelial cells in mucosal tissues. J Immunol 2000: 165: 2943-2949.
5. Lazarus N H, Kunkel E J, Johnston B, Wilson E, Youngman K R, Butcher E C. A common mucosal chemokine (mucosae-associated epithelial chemokine/ CCL28) selectively attracts IgA plasmablasts. J Immunol 2003: 170: 3799-3805.
6. Brandtzaeg P, Farstad I N, Haraldsen G. Regional specialization in the mucosal immune system: Primed cells do not always home along the same track. Immunol Today 1999: 20: 267-277.
7. Wang W, Soto H, Oldham E R et al. Identification of a novel CC chemokine (CCL28) which binds CCR10 (GPR2). J Biol Chem 2000: 275: 22313-22323.
8. Kagami S, Kakinuma T, Saeki H et al. Increased serum CCL28 levels in patients with atopic dermatitis, psoriasis vulgaris and bullous pemphigoid. J Invest Dermatol 2005: 124: 1088-1090.
9. Vestergaard C, Bang K, Gesser B, Yoneyama H, Matsushima K, Larsen C G. Expression of the T-helper 2-specific chemokine receptor CCR4 on CCR10-positive lymphocytes in atopic dermatitis skin but not in psoriasis skin. Br J Dermatol 2000: 149: 457-463.
10. Tapia B, Padial A, Sanchez-Sabate E et al. Involvement of CCL27-CCR10 interactions in drug-induced cutaneous reactions. J Allergy Clin Immunol 2004: 114: 335-340.
11. Moed H, Boorsma D M, Tensen C P et al. Increased CCL27-CCR10 expression in allergic contact dermatitis: Implications for local skin memory. J Pathol 2004: 204: 39-46.
12. Homey B, Alenius H, Muller A et al. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med 2002: 8: 157-165.
13. Spiekstra S W, Toebak M J, Sampat-Sardjoepersad S et al. Induction of cytokine (interleukin-1alpha and tumor necrosis factor-alpha) and chemokine (CCL20, CCL27, and CXCL8) alarm signals after allergen and irritant exposure. Exp Dermatol 2005: 14: 109-116.
14. Kanda N, Mitsui H, Watanabe S. Prostaglandin E 2 suppresses CCL27 production through EP2 and EP3 receptors in human keratinocytes. J Allergy Clin Immunol 2004: 114: 1403-1409.
15. Vestergaard C, Johansen C, Otkjaer K, Deleuran M, Iversen L. Tumor necrosis factor-α-induced CTACK/CCL27 (cutaneous T-cell-attracting chemokine) production in keratinocytes is controlled by nuclear factor κB. Cytokine 2005: 29: 49-55.
16. Ogawa H, Iimura M, Eckmann L, Kagnoff M F. Regulated production of the chemokine CCL28 in human colon epithelium. Am J Physiol Gastrointest Liver Physiol 2004: 287: G1062-G1069.
17. Duh E J, Maury W J, Folks T M, Fauci A S, Rabson A B. Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappaB sites in the long terminal repeat. Proc Natl Acad Sci USA 1989: 86: 5974-5978.
18. Kyriakis J M, Banerjee P, Nikolakaki E et al. The stress-activated protein kinase subfamily of c-Jun kinases. Nature 1994: 369: 156-160.
19. Donato N J, Gallick G E, Steck P A, Rpsenblum M G. Tumor necrosis factor modulates epidermal growth factor receptor phosphorylation and kinase activity in human tumor cells. Correlation with cytotoxicity. J Biol Chem 1989: 264: 20474-20481.
20. Holvoet S, Vincent C, Schmitt D, Serres M. The inhibition of MAPK pathway is correlated with down-regulation of MMP-9 secretion induced by TNF-alpha in human keratinocytes. Exp Cell Res 2003: 290: 108-119.
21. Tomic-Canic M, Komine M, Freedberg I M, Blumenberg M. Epidermal signal transduction and transcription factor activation in activated keratinocytes. J Dermatol Sci 1998: 17: 167-181.
22. Wang C C, Lin W N, Lee C W et al. Involvement of p42/p44 MAPK, p38 MAPK, JNK and NF-{kappa}B in interleukin-1β-induced VCAM-1 expression in human tracheal smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2005: 288: L227-L237.
23. Tanida S, Joh T, Itoh K et al. The mechanism of cleavage of EGFR ligands induced by inflammatory cytokines in gastric cancer cells. Gastroenterology 2004: 127: 559-569.